Reply to: Safety of dopamine agonists for treating restless legs syndrome
about
Reply to: Safety of dopamine agonists for treating restless legs syndrome
description
scientific article published on 01 January 2019
@en
name
Reply to: Safety of dopamine agonists for treating restless legs syndrome
@en
type
label
Reply to: Safety of dopamine agonists for treating restless legs syndrome
@en
prefLabel
Reply to: Safety of dopamine agonists for treating restless legs syndrome
@en
P2093
P356
P1433
P1476
Reply to: Safety of dopamine agonists for treating restless legs syndrome
@en
P2093
Aaro V Salminen
Claudia Trenkwalder
Cristina Sampaio
John W Winkelman
Juliane Winkelmann
Richard P Allen
Wolfgang Oertel
Yuichi Inoue
P304
P356
10.1002/MDS.27571
P50
P577
2019-01-01T00:00:00Z